Publications Identifying Outcomes in Clinical Trials of Fistulizing Crohn’s Disease for the Development of a Core Outcome Set Citation Ma C, Parker CE, Nguyen TM, Khanna R, Feagan BG, Jairath V. Identifying Outcomes in Clinical Trials of Fistulizing Crohn's Disease for the Development of a Core Outcome Set. Clin Gastroenterol Hepatol. 2019 Aug;17(9):1904-1908. doi: 10.1016/j.cgh.2018.10.004. Epub 2018 Oct 4. PMID: 30292887. Abstract Fistulizing complications develop in approximately one third of patients with Crohn’s disease (CD), resulting in morbidity and impaired quality of life. Tags Crohn's Disease, Cutaneous Fistula, Gastrointestinal Agents, Immunosuppressive Agents, Intestinal Fistula, Mesenchymal Stem Cell Transplantation, Physiopathology, Rectal Fistula, Rectovaginal Fistula, therapeutic use, Therapy, Treatment Outcome, Urinary Fistula Read More
